Mig and IP-10: CXC chemokines that target lymphocytes

被引:683
作者
Farber, JM
机构
[1] Laboratory of Clinical Investigation, Natl. Inst. Allerg. and Infect. Dis., National Institutes of Health, Bethesda, MD
[2] Bldg. 10, NIH, Bethesda, MD 20892
关键词
cytokines; interferon; T cells; infection; angiogenesis; cancer;
D O I
10.1002/jlb.61.3.246
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Mg and IP-10 are related members of the CXC subfamily of the chemokine family of cytokines. The murine Mig (MuMig), human IP-10, and the mouse homologue of IP-10, Crg-2, were all identified due to the dramatic inductions of their genes in monocytic cells treated with interferon-gamma (IFN-gamma), Studies using recombinant (r) human proteins show that, unlike most other CXC chemokines, rHuMig and rIP-10 have no activity on neutrophils but appear to target lymphocytes specifically, rHuMig and rIP-10 are active as chemotactic factors for stimulated, but not for resting, T cells, Studies done in vitro and in vivo have shown that rHuMig and rIP-10 share additional activities, including inhibition of neovascularization, inhibition of hematopoietic progenitor cells, and anti-tumor effects, rHuMig and rIP-10 show reciprocal desensitization on activated T cells and have been demonstrated to share a receptor, CXCR3, The genes for both MuMig, and Crg-2 are highly expressed in multiple tissues during experimental viral and protozoan infections in mice, but their patterns of expression differ, This suggests that the Migs and IP-10/Crg-2 may play roles in host defense and that, despite their similar activities assayed in vitro, Mig and IP-10/Crg-2 may serve non-redundant functions in vivo.
引用
收藏
页码:246 / 257
页数:12
相关论文
共 45 条
[1]
Amichay D, 1996, J IMMUNOL, V157, P4511
[2]
ANGIOLILLO AL, 1995, J EXP MED, V182, P1301
[3]
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Morris, SB ;
Burdick, MD ;
Glass, MC ;
Taub, DT ;
Iannettoni, MD ;
Whyte, TI ;
Strieter, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :981-992
[4]
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[5]
JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[6]
A COLLECTION OF MESSENGER-RNA SPECIES THAT ARE INDUCIBLE IN THE RAW-264.7 MOUSE MACROPHAGE CELL-LINE BY GAMMA INTERFERON AND OTHER AGENTS [J].
FARBER, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (04) :1535-1545
[7]
HUMIG - A NEW HUMAN MEMBER OF THE CHEMOKINE FAMILY OF CYTOKINES [J].
FARBER, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) :223-230
[9]
CONSTITUTIVE EXPRESSION OF INTERFERON GAMMA-INDUCIBLE PROTEIN-10 IN LYMPHOID ORGANS AND INDUCIBLE EXPRESSION IN T-CELLS AND THYMOCYTES [J].
GATTASS, CR ;
KING, LB ;
LUSTER, AD ;
ASHWELL, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1373-1378
[10]
CHEMOKINE EXPRESSION IN MURINE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
GODISKA, R ;
CHANTRY, D ;
DIETSCH, GN ;
GRAY, PW .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 58 (02) :167-176